{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:10:55Z","timestamp":1794003055286,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02753-x","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:02:16Z","timestamp":1785715336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BCL9 inhibition promotes fibroblast lipogenesis by regulating macrophage\u2013fibroblast interactions to attenuate pulmonary fibrosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Wenjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-7999","authenticated-orcid":false,"given":"Dafu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-9017","authenticated-orcid":false,"given":"Ming-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-4600","authenticated-orcid":false,"given":"Di","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-4188","authenticated-orcid":false,"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-2543","authenticated-orcid":false,"given":"Bingshun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2753_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"2753_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu, G. et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788\u2013824 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2753_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/resp.12683","volume":"21","author":"G Sgalla","year":"2016","unstructured":"Sgalla, G., Biffi, A. & Richeldi, L. Idiopathic pulmonary fibrosis: diagnosis, epidemiology and natural history. Respirology 21, 427\u2013437 (2016).","journal-title":"Respirology"},{"key":"2753_CR4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071\u20132082 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2753_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","volume":"365","author":"L Richeldi","year":"2011","unstructured":"Richeldi, L. et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N. Engl. J. Med. 365, 1079\u20131087 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2753_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","volume":"158","author":"G Raghu","year":"2013","unstructured":"Raghu, G. et al. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann. Intern. Med. 158, 641\u2013649 (2013).","journal-title":"Ann. Intern. Med."},{"key":"2753_CR7","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.4049\/jimmunol.171.6.3128","volume":"171","author":"M Gonzalez-Juarrero","year":"2003","unstructured":"Gonzalez-Juarrero, M., Shim, T. S., Kipnis, A., Junqueira-Kipnis, A. P. & Orme, I. M. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171, 3128\u20133135 (2003).","journal-title":"J. Immunol."},{"key":"2753_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"2753_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fmed.2018.00043","volume":"5","author":"O Desai","year":"2018","unstructured":"Desai, O., Winkler, J., Minasyan, M. & Herzog, E. L. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front. Med. 5, 43 (2018).","journal-title":"Front. Med."},{"key":"2753_CR10","doi-asserted-by":"publisher","first-page":"e1006437","DOI":"10.1371\/journal.ppat.1006437","volume":"13","author":"J Mesureur","year":"2017","unstructured":"Mesureur, J. et al. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog. 13, e1006437 (2017).","journal-title":"PLoS Pathog."},{"key":"2753_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23\u201335 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"2753_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","volume":"43","author":"LA Murray","year":"2011","unstructured":"Murray, L. A. et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int. J. Biochem. Cell Biol. 43, 154\u2013162 (2011).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2753_CR13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. Transforming growth factor-\u03b2 in tissue fibrosis. J. Exp. Med. 217, e20190103 (2020).","journal-title":"J. Exp. Med."},{"key":"2753_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1164\/rccm.201010-1719OC","volume":"184","author":"MA Gibbons","year":"2011","unstructured":"Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569\u2013581 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2753_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480 (2006).","journal-title":"Cell"},{"key":"2753_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.it.2018.08.006","volume":"39","author":"W-J Chae","year":"2018","unstructured":"Chae, W.-J. & Bothwell, A. L. M. Canonical and non-canonical Wnt signaling in immune cells. Trends Immunol. 39, 830\u2013847 (2018).","journal-title":"Trends Immunol."},{"key":"2753_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1681\/ASN.2017040391","volume":"29","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Wnt\/\u03b2-catenin-promoted macrophage alternative activation contributes to kidney fibrosis. J. Am. Soc. Nephrol. 29, 182\u2013193 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2753_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1165\/rcmb.2016-0394ED","volume":"56","author":"EF Redente","year":"2017","unstructured":"Redente, E. F. Macrophages and fibrosis resolution. Harnessing Wnt\/\u03b2-catenin signaling as the way and the means. Am. J. Respir. Cell Mol. Biol. 56, 150\u2013151 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2753_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0300-8","volume":"16","author":"J Hou","year":"2018","unstructured":"Hou, J. et al. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis. Cell Commun. Signal 16, 89 (2018).","journal-title":"Cell Commun. Signal"},{"key":"2753_CR20","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64282-4","volume":"162","author":"M Chilosi","year":"2003","unstructured":"Chilosi, M. et al. Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 162, 1495\u20131502 (2003).","journal-title":"Am. J. Pathol."},{"key":"2753_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.diff.2022.03.004","volume":"125","author":"C Shi","year":"2022","unstructured":"Shi, C. et al. Wnt8b regulates myofibroblast differentiation of lung-resident mesenchymal stem cells via the activation of Wnt\/\u03b2-catenin signaling in pulmonary fibrogenesis. Differentiation 125, 35\u201344 (2022).","journal-title":"Differentiation"},{"key":"2753_CR22","doi-asserted-by":"publisher","first-page":"176293","DOI":"10.1016\/j.ejphar.2023.176293","volume":"964","author":"J-Z Yin","year":"2023","unstructured":"Yin, J.-Z. et al. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt\/GSK-3\u03b2\/\u03b2-catenin signaling pathway. Eur. J. Pharmacol. 964, 176293 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"2753_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-024-02786-2","volume":"25","author":"M Patel","year":"2024","unstructured":"Patel, M. et al. A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model. Respir. Res. 25, 153 (2024).","journal-title":"Respir. Res."},{"key":"2753_CR24","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1371\/journal.pone.0002142","volume":"3","author":"M K\u00f6nigshoff","year":"2008","unstructured":"K\u00f6nigshoff, M. et al. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE 3, e2142 (2008).","journal-title":"PLoS ONE"},{"key":"2753_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1183\/09031936.00142409","volume":"37","author":"EM Pfaff","year":"2010","unstructured":"Pfaff, E. M., Becker, S., G\u00fcnther, A. & K\u00f6nigshoff, M. Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis. Eur. Respir. J. 37, 79\u201387 (2010).","journal-title":"Eur. Respir. J."},{"key":"2753_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1165\/rcmb.2016-0147OC","volume":"56","author":"JA Sennello","year":"2017","unstructured":"Sennello, J. A. et al. Lrp5\/\u03b2-catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis. Am. J. Respir. Cell Mol. Biol. 56, 191\u2013201 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2753_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1164\/rccm.201401-0079OC","volume":"190","author":"AP Lam","year":"2014","unstructured":"Lam, A. P. et al. Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 190, 185\u2013195 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2753_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn, M. Can we safely target the WNT pathway?. Nat. Rev. Drug Discov. 13, 513\u2013532 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2753_CR29","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/emboj.2012.126","volume":"31","author":"P Polakis","year":"2012","unstructured":"Polakis, P. Drugging Wnt signalling in cancer. EMBO J. 31, 2737\u20132746 (2012).","journal-title":"EMBO J."},{"key":"2753_CR30","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1073\/pnas.0610299104","volume":"104","author":"K Sukhdeo","year":"2007","unstructured":"Sukhdeo, K. et al. Targeting the beta-catenin\/TCF transcriptional complex in the treatment of multiple myeloma. Proc. Natl. Acad. Sci. USA 104, 7516\u20137521 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2753_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrm2654","volume":"10","author":"C Mosimann","year":"2009","unstructured":"Mosimann, C., Hausmann, G. & Basler, K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 10, 276\u2013286 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2753_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41392-024-01838-9","volume":"9","author":"F He","year":"2024","unstructured":"He, F. et al. Targeting BCL9\/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration. Signal Transduct. Target Ther. 9, 139 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2753_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13842-7","volume":"11","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins. Nat. Commun. 11, 19 (2020).","journal-title":"Nat. Commun."},{"key":"2753_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre, T. et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci. Immunol. 8, eadd8945 (2023).","journal-title":"Sci. Immunol."},{"key":"2753_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1164\/rccm.201103-0561OC","volume":"185","author":"Y Aono","year":"2012","unstructured":"Aono, Y. et al. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury. Am. J. Respir. Crit. Care Med. 185, 525\u2013536 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2753_CR36","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse, C. et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019).","journal-title":"Eur. Respir. J."},{"key":"2753_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017071","volume":"9","author":"K Shirakawa","year":"2020","unstructured":"Shirakawa, K. et al. MerTK expression and ERK activation are essential for the functional maturation of osteopontin-producing reparative macrophages after myocardial infarction. J. Am. Heart Assoc. 9, e017071 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"2753_CR38","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1089\/ars.2013.5793","volume":"21","author":"VK Rehan","year":"2014","unstructured":"Rehan, V. K. & Torday, J. S. The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid. Redox Signal 21, 1893\u20131904 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"2753_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.stem.2016.10.004","volume":"20","author":"E El Agha","year":"2017","unstructured":"El Agha, E. et al. Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis. Cell Stem Cell 20, 261\u2013273 (2017).","journal-title":"Cell Stem Cell"},{"key":"2753_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10839-0","volume":"10","author":"V Kheirollahi","year":"2019","unstructured":"Kheirollahi, V. et al. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis. Nat. Commun. 10, 2987 (2019).","journal-title":"Nat. Commun."},{"key":"2753_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl5473","volume":"10","author":"CH Mayr","year":"2024","unstructured":"Mayr, C. H. et al. Spatial transcriptomic characterization of pathologic niches in IPF. Sci. Adv. 10, eadl5473 (2024).","journal-title":"Sci. Adv."},{"key":"2753_CR42","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.scr.2013.08.007","volume":"11","author":"JL McQualter","year":"2013","unstructured":"McQualter, J. L. et al. TGF-\u03b2 signaling in stromal cells acts upstream of FGF-10 to regulate epithelial stem cell growth in the adult lung. Stem Cell Res. 11, 1222\u20131233 (2013).","journal-title":"Stem Cell Res."},{"key":"2753_CR43","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1172\/JCI68782","volume":"123","author":"CE Barkauskas","year":"2013","unstructured":"Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Investig. 123, 3025\u20133036 (2013).","journal-title":"J. Clin. Investig."},{"key":"2753_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/toxsci\/kfy309","volume":"168","author":"DL Laskin","year":"2019","unstructured":"Laskin, D. L., Malaviya, R. & Laskin, J. D. Role of macrophages in acute lung injury and chronic fibrosis induced by pulmonary toxicants. Toxicol. Sci. 168, 287\u2013301 (2019).","journal-title":"Toxicol. Sci."},{"key":"2753_CR45","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1111\/jcmm.16821","volume":"25","author":"H Ying","year":"2021","unstructured":"Ying, H. et al. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-\u03b21\/Smad3 pathway. J. Cell Mol. Med. 25, 8662\u20138675 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"2753_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1269\/jrr.11054","volume":"52","author":"H Zhang","year":"2011","unstructured":"Zhang, H. et al. The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice. J. Radiat. Res. 52, 717\u2013726 (2011).","journal-title":"J. Radiat. Res."},{"key":"2753_CR47","doi-asserted-by":"publisher","first-page":"14309","DOI":"10.1073\/pnas.1001520107","volume":"107","author":"WR Henderson","year":"2010","unstructured":"Henderson, W. R. et al. Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 107, 14309\u201314314 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2753_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-13-62","volume":"13","author":"T Meuten","year":"2012","unstructured":"Meuten, T. et al. WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis. Respir. Res. 13, 62 (2012).","journal-title":"Respir. Res."},{"key":"2753_CR49","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1164\/rccm.201908-1573OC","volume":"202","author":"M Zysman","year":"2020","unstructured":"Zysman, M. et al. Targeting p16INK4a promotes lipofibroblasts and alveolar regeneration after early-life injury. Am. J. Respir. Crit. Care Med. 202, 1088\u20131104 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2753_CR50","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1183\/09031936.00182412","volume":"42","author":"CJ Scotton","year":"2013","unstructured":"Scotton, C. J. et al. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation. Eur. Respir. J. 42, 1633\u20131645 (2013).","journal-title":"Eur. Respir. J."},{"key":"2753_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."},{"key":"2753_CR52","first-page":"893","volume":"120","author":"SV Szapiel","year":"1979","unstructured":"Szapiel, S. V., Elson, N. A., Fulmer, J. D., Hunninghake, G. W. & Crystal, R. G. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis. 120, 893\u2013899 (1979).","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02753-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02753-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02753-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:02:17Z","timestamp":1785715337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02753-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02753-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"305"}}